752 related articles for article (PubMed ID: 25874605)
1. The Interplay between Alpha-Synuclein Clearance and Spreading.
Lopes da Fonseca T; Villar-Piqué A; Outeiro TF
Biomolecules; 2015 Apr; 5(2):435-71. PubMed ID: 25874605
[TBL] [Abstract][Full Text] [Related]
2. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
[TBL] [Abstract][Full Text] [Related]
3. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.
Tanik SA; Schultheiss CE; Volpicelli-Daley LA; Brunden KR; Lee VM
J Biol Chem; 2013 May; 288(21):15194-210. PubMed ID: 23532841
[TBL] [Abstract][Full Text] [Related]
4. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
Hansen C; Li JY
Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
[TBL] [Abstract][Full Text] [Related]
5. Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein.
Kang SJ; Kim SJ; Noh HR; Kim BJ; Kim JB; Jin U; Park SA; Park SM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955451
[TBL] [Abstract][Full Text] [Related]
6. A Cleaning Crew: The Pursuit of Autophagy in Parkinson's Disease.
Parekh P; Sharma N; Gadepalli A; Shahane A; Sharma M; Khairnar A
ACS Chem Neurosci; 2019 Sep; 10(9):3914-3926. PubMed ID: 31385687
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
8. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
[TBL] [Abstract][Full Text] [Related]
9. The dual role of c-src in cell-to-cell transmission of α-synuclein.
Choi YR; Kim JB; Kang SJ; Noh HR; Jou I; Joe EH; Park SM
EMBO Rep; 2020 Jul; 21(7):e48950. PubMed ID: 32372484
[TBL] [Abstract][Full Text] [Related]
10. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
11. α-Synuclein Propagation Mouse Models of Parkinson's Disease.
Uemura N; Ueda J; Okuda S; Sawamura M; Takahashi R
Methods Mol Biol; 2021; 2322():119-130. PubMed ID: 34043198
[TBL] [Abstract][Full Text] [Related]
12. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
Vargas JY; Grudina C; Zurzolo C
Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
[TBL] [Abstract][Full Text] [Related]
13. Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease.
Fares MB; Maco B; Oueslati A; Rockenstein E; Ninkina N; Buchman VL; Masliah E; Lashuel HA
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E912-21. PubMed ID: 26839406
[TBL] [Abstract][Full Text] [Related]
14. Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.
Rey NL; George S; Brundin P
Neuropathol Appl Neurobiol; 2016 Feb; 42(1):51-76. PubMed ID: 26666838
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
Filippini A; Gennarelli M; Russo I
Cell Mol Neurobiol; 2019 Mar; 39(2):161-168. PubMed ID: 30637614
[TBL] [Abstract][Full Text] [Related]
16. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
Li B; Zhang Y; Yuan Y; Chen N
Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
Xu S; Chan P
Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease.
Kim KS; Choi YR; Park JY; Lee JH; Kim DK; Lee SJ; Paik SR; Jou I; Park SM
J Biol Chem; 2012 Jul; 287(30):24862-72. PubMed ID: 22619171
[TBL] [Abstract][Full Text] [Related]
19. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
[TBL] [Abstract][Full Text] [Related]
20. Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease.
Park SJ; Jin U; Park SM
PLoS Pathog; 2021 Oct; 17(10):e1010018. PubMed ID: 34695168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
